SC
BDSX icon

Shay Capital’s Biodesix BDSX Stock Holding History

Shay Capital’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-16,145
Closed -$110K – 501
2025
Q4 		$110K Buy
16,145
+2,140
+15% +$15.8K 0.01% 444
2025
Q3 		$106K Buy
14,005
+2,455
+21% +$18.9K 0.01% 380
2025
Q2 		$65.2K Sell
11,550
-1,820
-14% -$14.7K 0.01% 289
2025
Q1 		$167K Sell
13,370
-708
-5% -$13.6K 0.02% 249
2024
Q4 		$431K Buy
+14,078
New +$414K 0.07% 194

Other funds holding BDSX

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return

Shay Capital's BDSX Position: Q1 2026 in Review

Shay Capital sold out of Biodesix (BDSX) in Q1 2026, closing a stake of 16,145 shares — an estimated $110K sold.

Shay Capital first reported a position in BDSX in Q4 2024 and held it in 5 quarters. The position peaked at $431K in Q4 2024. 40 funds tracked by Wall St. Rank hold BDSX as of Q1 2026.

  • Shay Capital reported no remaining Biodesix position as of Q1 2026 after selling out during the quarter.
  • Shay Capital sold 16,145 Biodesix shares in Q1 2026, an estimated $110K.
  • Shay Capital first reported a position in Biodesix in Q4 2024 and held it in 5 quarters.
  • Shay Capital's Biodesix position peaked at $431K in Q4 2024.
  • 40 funds tracked by Wall St. Rank held Biodesix as of Q1 2026.

Based on Shay Capital's 13F filing for Q1 2026, filed 15 May 2026.